Dr. Roscoe M. Moore, Jr. is a former United States Assistant Surgeon-General and a retired Rear-Admiral, United States Public Health Service (USPHS). Until his retirement, He served with the United States Department of Health and Human Services (HHS) and was for the last twelve years of his career the principal person responsible for development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less developed countries of the world (e.g., Indonesia, Malaysia, and Vietnam). He was the principal liaison person between the HHS and Ministries of Health in Africa with regard to the development of infrastructure and technical support for the delivery of preventive and curative health needs for the continent. Dr. Moore represented the HHS in cooperative international efforts with African nations in addressing continued health and human resources problems.

Dr. Moore received his undergraduate and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Master of Public Health degree in Epidemiology from the University of Michigan; and his Doctor of Philosophy degree in Epidemiology from the Johns Hopkins University. He was awarded the Honorary Doctor of Science degree in recognition of his distinguished public health career by Tuskegee University.

Dr. Moore was selected as Chief Veterinary Medical Officer, USPHS by Surgeon General C. Everett Koop. He served as the Chief Epidemiologist with the Center for Devices and Radiological Health, Food and Drug Administration (FDA). He directed the Epidemiology and Biostatistics Program and was an Assistant Professor of Oncology within the Howard University College of Medicine Cancer Center. Dr. Moore has extensive experience in clinical and public health research, and anti-bioterrorism policy issues. Dr. Moore has written or co-authored over 100 publications covering a broad range of public health issues.

Dr. Moore is Founder and President of PH RockWood Corporation. PH RockWood Corporation is focused on the prevention, treatment and control of infectious diseases worldwide. He is a Senior Fellow of the Potomac Institute of Policy Studies. Dr. Moore is the Chair of the Business Advisory Board of Immunomic Therapeutics Incorporated, a privately held DNA vaccine company. He serves as a Commissioner for the Maryland Health Care Commission, appointed by the Governor. Dr. Moore serves of the Board of Trustees for Friends of the University of Stellenbosch Foundation. He is a Fellow of the American College of Epidemiology.